IP Verse

Michalski Hutteramnn & Partner Patentanwalte Mbb competitive analysis

Loading summary...

Latest oppositions filed by Michalski Hutteramnn & Partner Patentanwalte Mbb

Explore patent oppositions filed by Michalski Hutteramnn & Partner Patentanwalte Mbb against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3973987
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 10, 2024
EP3589661
Adjuvant Treatment Of Her2-Positive Breast CancerF HOFFMANN LA ROCHEAug 1, 2024
EP3703818
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSAug 1, 2024

Latest publications and patents of Michalski Hutteramnn & Partner Patentanwalte Mbb New

Explore the latest publications and patents granted to Michalski Hutteramnn & Partner Patentanwalte Mbb, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Michalski Hutteramnn & Partner Patentanwalte Mbb

Discover the latest PTAB cases involving Michalski Hutteramnn & Partner Patentanwalte Mbb, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Michalski Hutteramnn & Partner Patentanwalte Mbb with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MICHALSKI HUTTERAMNN & PARTNER PATENTANWALTE MBB3 - - -
F HOFFMANN LA ROCHE16140 - -
REGENERON PHARMACEUTICALS3894931
SANOFI BIOTECHNOLOGY - 51 - -